{'fraction_non_alphanumeric': 0.030560271646859084, 'fraction_numerical': 0.0, 'mean_word_length': 5.8604651162790695, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Assessing the accuracy of a point‐of‐care analyzer for hyperlipidaemia in western Kenya

The prevalence of hyperlipidaemia, along with other non‐communicable diseases, is on the rise in low‐ and middle‐income countries. CardioChek PA is a point‐of‐care lipid measuring device, which seeks to overcome laboratory‐based diagnostic barriers by providing immediate results without dependency on significant laboratory infrastructure. However, it has not been validated in Kenya. In this study, we assess the accuracy of CardioChek PA with respect to the gold standard laboratory‐based testing.